CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Autoimmune Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Autoimmune Inc
1199 Madia Street
Phone: (626) 792-1235p:626 792-1235 PASADENA, CA  91103  United States Fax: (302) 655-5049f:302 655-5049

This company ceased filing statements with the SEC on 3/9/2010.
This company is no longer actively traded on any major stock exchange.

Business Summary
AutoImmune Inc. is a healthcare company. The Company’s products are based on the principles of mucosal tolerance. The Company’s product is sold by Colloral LLC, the Company’s joint venture with Deseret, under the brand name Colloral, The Collagen Solution and Vital 3, and by Futurebiotics LLC under the brand name Vital 3. The other products which are in the development stage include MBP8298 (dirucotide), Oral Copaxone and AI 401.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200912/31/2008YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Robert C.Bishop 68 5/2/1999 5/1/1992
Treasurer, Director of Finance Diane M.McClintock 43 8/18/2005 8/18/2005
Director Hugh A.D'Andrade 72 1/1/1994 1/1/1994
Director Allan R.Ferguson 68 1/1/1988 1/1/1988
Director R. JohnFletcher 67 1/1/1991 1/1/1991

General Information
Outstanding Shares: 16,999,623 (As of 3/19/2010)
Shareholders: 2,450
Stock Exchange: OTC
Federal Tax Id: 133489062
Fax Number: (302) 655-5049


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023